Both hepatitis B virus and Helicobacter pylori can induce the enrichment of MDSCs in cancer tissues, resulting in an imbalance in the proportion of CD4+ and CD8+ T-cell subsets and producing the inactivation of antitumour immunity and the malignant proliferation of cancer cells [40–41]. The gene discussed is CD4; the disease is cancer.